Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2016 6
2017 9
2018 8
2019 12
2020 11
2021 12
2022 8
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for salvatore alfieri
Search for Salvatore Alfiero instead (3 results)
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Bossi P. Baggi A, et al. Among authors: alfieri s. Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536948
HER2-targeted therapies for salivary gland cancers.
Filippini DM, Pagani R, Tober N, Lorini L, Riefolo M, Molinari G, Burato A, Alfieri S, Bossi P, Presutti L. Filippini DM, et al. Among authors: alfieri s. Oral Oncol. 2024 Jan;148:106612. doi: 10.1016/j.oraloncology.2023.106612. Epub 2023 Nov 27. Oral Oncol. 2024. PMID: 38016228 Free article. Review.
Immunotherapy for recurrent/metastatic head and neck cancer.
Alfieri S, Cavalieri S, Licitra L. Alfieri S, et al. Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):152-156. doi: 10.1097/MOO.0000000000000448. Curr Opin Otolaryngol Head Neck Surg. 2018. PMID: 29432222 Review.
The point of pain in head and neck cancer.
Bossi P, Giusti R, Tarsitano A, Airoldi M, De Sanctis V, Caspiani O, Alterio D, Tartaro T, Alfieri S, Siano M. Bossi P, et al. Among authors: alfieri s. Crit Rev Oncol Hematol. 2019 Jun;138:51-59. doi: 10.1016/j.critrevonc.2019.04.001. Epub 2019 Apr 5. Crit Rev Oncol Hematol. 2019. PMID: 31092385 Review.
The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer.
Denaro N, Romanò R, Alfieri S, Dolci A, Licitra L, Nuzzolese I, Ghidini M, Bareggi C, Bertaglia V, Solinas C, Garrone O. Denaro N, et al. Among authors: alfieri s. Cancers (Basel). 2023 Apr 25;15(9):2458. doi: 10.3390/cancers15092458. Cancers (Basel). 2023. PMID: 37173925 Free PMC article. Review.
Investigational drugs for head and neck cancer.
Bossi P, Alfieri S. Bossi P, et al. Among authors: alfieri s. Expert Opin Investig Drugs. 2016 Jul;25(7):797-810. doi: 10.1080/13543784.2016.1175435. Epub 2016 Apr 25. Expert Opin Investig Drugs. 2016. PMID: 27054910 Review.
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.
Viscardi G, Tralongo AC, Massari F, Lambertini M, Mollica V, Rizzo A, Comito F, Di Liello R, Alfieri S, Imbimbo M, Della Corte CM, Morgillo F, Simeon V, Lo Russo G, Proto C, Prelaj A, De Toma A, Galli G, Signorelli D, Ciardiello F, Remon J, Chaput N, Besse B, de Braud F, Garassino MC, Torri V, Cinquini M, Ferrara R. Viscardi G, et al. Among authors: alfieri s. Eur J Cancer. 2022 Dec;177:175-185. doi: 10.1016/j.ejca.2022.09.031. Epub 2022 Oct 5. Eur J Cancer. 2022. PMID: 36368251 Review.
The Case Volume Issue in Head and Neck Oncology.
Alfieri S, Orlandi E, Bossi P. Alfieri S, et al. Curr Treat Options Oncol. 2017 Oct 27;18(11):65. doi: 10.1007/s11864-017-0507-8. Curr Treat Options Oncol. 2017. PMID: 29079897 Review.
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Roberti E, Merlano M, Ravanelli M, Alberti A, Esposito A, Gili R, Spinazzé S, Baré C, Jocollé G, Benasso M, Bertolotti F, Vecchio S, Bacigalupo A, Licitra L, Denaro N, Damico M, Lorini L, Gurizzan C, Alfieri S, Bossi P. Roberti E, et al. Among authors: alfieri s. Oral Oncol. 2023 Oct;145:106540. doi: 10.1016/j.oraloncology.2023.106540. Epub 2023 Aug 9. Oral Oncol. 2023. PMID: 37567147 Clinical Trial.
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology.
Muraro E, Romanò R, Fanetti G, Vaccher E, Turturici I, Lupato V, La Torre FB, Polesel J, Fratta E, Giacomarra V, Franchin G, Steffan A, Spina M, Alfieri S. Muraro E, et al. Among authors: alfieri s. Crit Rev Oncol Hematol. 2022 Jul;175:103707. doi: 10.1016/j.critrevonc.2022.103707. Epub 2022 May 13. Crit Rev Oncol Hematol. 2022. PMID: 35569724 Review.
70 results